Ceryvyn Therapeutics Limited (CYVNY) Stock Statistics & Valuation Metrics

Ceryvyn Therapeutics Limited has a market cap or net worth of $11.50M. The enterprise value is -$18.21.

Ceryvyn Therapeutics Limited has 170,997,270 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ceryvyn Therapeutics Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Ceryvyn Therapeutics Limited is ―. Ceryvyn Therapeutics Limited’s PEG ratio is -0.00133.

In the last 12 months, Ceryvyn Therapeutics Limited had revenue of ― and earned ― in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Ceryvyn Therapeutics Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Ceryvyn Therapeutics Limited upcoming earnings date is Aug 28, 2026, TBA (Confirmed).

Ceryvyn Therapeutics Limited as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Ceryvyn Therapeutics Limited has paid ― in taxes.

Ceryvyn Therapeutics Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Ceryvyn Therapeutics Limited has ― in cash and marketable securities with $141.65M in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Ceryvyn Therapeutics Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―